B lymphocytes, also called B cells, are the white blood cells that produce antibodies, the Y-shaped proteins that latch onto germs and mark them for destruction. Each B cell is born able to recognize just one shape, so the body keeps millions of different B cells waiting for a match. Most will never meet their target, but the few that do can protect you for decades.
How a B Cell Gets Its One-of-a-Kind Receptor
B cells develop in the bone marrow, the soft tissue inside large bones. There, each young B cell picks one piece from each of three sets of gene segments and stitches them together to build its receptor.1PubMed Central. V(D)J recombination, somatic hypermutation and class switch recombination of immunoglobulins: mechanism and regulation The number of possible combinations is enormous, which is how the body covers germs it has never seen.2PubMed Central. V(D)J recombination, somatic hypermutation and class switch recombination of immunoglobulins: mechanism and regulation That randomness is risky: some of those random receptors will inevitably match the body’s own tissues, which is why a safety check follows.
The building happens in two stages. The cell first builds the receptor’s heavy part and tests that it works, then builds the light part.3PubMed Central. V(D)J recombination process and the Pre-B to immature B-cells transition are altered in Fanca−/− mice Only cells with a working, assembled receptor move on to the next stage.4PubMed Central. V(D)J recombination process and the Pre-B to immature B-cells transition are altered in Fanca−/− mice Cells that fail generally die rather than getting endless attempts, so the marrow makes far more young cells than ever leave it. The light part can be rebuilt later if needed, which is what makes the editing described in the next section possible.
The receptor sitting on a B cell’s surface is essentially the antibody it will later release into the blood. So what the receptor recognizes decides what that cell’s antibodies will target. The tip of the Y is the part that varies and grabs the target, while the stem is the same across many antibodies and signals other immune cells.
The Safety Check Against Attacking Yourself
Because receptors are built at random, some young B cells react to the body’s own molecules.5Antibodies. B Cell Tolerance in Health and Disease Young B cells are tested against those molecules before they leave the bone marrow.6PubMed Central. V(D)J recombination process and the Pre-B to immature B-cells transition are altered in Fanca−/− mice “Self,” to a young cell, means molecules abundant in the marrow, such as proteins on the surfaces of the body’s own cells. A strong grip on one of these is the warning sign. A weak, passing contact is treated differently, so not every self-reactive cell is removed or silenced at this stage.
A cell that fails can reshuffle its genes to build a new receptor.7PubMed Central. Mechanisms of central tolerance for B cells It swaps the light part of the receptor for a new one. Cells that still react can be made to self-destruct.8PubMed Central. Mechanisms of central tolerance for B cells Others are switched into an unresponsive state instead.9Antibodies. B Cell Tolerance in Health and Disease Only cells beyond repair are removed. For cells reacting to molecules found on cell surfaces everywhere, editing is the main fix.10PubMed. Receptor editing is the main mechanism of B cell tolerance toward membrane antigens
The check isn’t perfect. Molecules found only in particular organs may not be present in the marrow, so a few self-reactive cells slip through even in healthy people. Further checks happen after cells leave the marrow, and when those fail, autoimmune disease can follow.
What Happens When a B Cell Meets Its Germ
When the receptor grabs its target, a relay of signaling proteins carries the message inside the cell.11PubMed Central. Mechanisms of B Cell Receptor Activation and Responses to B Cell Receptor Inhibitors in B Cell Malignancies Depending on context, that signal can make the cell multiply, mature, survive, or shut down.12PubMed Central. Mechanisms of B Cell Receptor Activation and Responses to B Cell Receptor Inhibitors in B Cell Malignancies One protein in this relay, BTK, is the target of some leukemia and lymphoma drugs.13PubMed Central. Mechanisms of B Cell Receptor Activation and Responses to B Cell Receptor Inhibitors in B Cell Malignancies
For most targets, B cells need a go-ahead from helper T cells before making antibodies.14Bioanalysis Zone. Understanding how biologics trigger immune responses: T-cell-dependent vs T-cell-independent pathways To get it, the B cell swallows its target and shows pieces of it to helper T cells.15PubMed Central. The Other Function: Class II-Restricted Antigen Presentation by B Cells It chops the germ into fragments and displays them on its surface. A helper T cell that recognizes the same fragment can lock on and give the go-ahead. Both cells must recognize the same germ, a double check before a full response starts. Some targets, such as certain bacterial components, can activate B cells without T cells.16Bioanalysis Zone. Understanding how biologics trigger immune responses: T-cell-dependent vs T-cell-independent pathways
This meeting happens mostly in lymph nodes or the spleen, which is why nodes near an infection often swell and feel tender. Early on, activated B cells make quick IgM antibodies. The slower sharpening process takes over later, and it needs around a week or two to get going, which is part of why a first infection or first vaccine dose doesn’t give peak protection right away.
Helped B cells gather in training zones inside lymph nodes and the spleen.17PubMed Central. Optimized Protocols for In-Vitro T-Cell-Dependent and T-Cell-Independent Activation for B-Cell Differentiation Studies Using Limited Cells There, an enzyme called AID deliberately introduces small mutations into the antibody genes.18PubMed. The biochemistry of somatic hypermutation Many cells try slightly different versions, and cells whose mutations grip the target better get stronger survival signals and divide faster.19PubMed Central. Regulated somatic hypermutation enhances antibody affinity maturation The fastest-dividing high-grip cells mutate less, protecting their good antibodies.20PubMed Central. Regulated somatic hypermutation enhances antibody affinity maturation Over weeks, antibodies get tighter, which is why later antibodies outperform early ones.
AID also lets cells switch antibody class, such as from IgM to IgG or IgA, while keeping the same target.21PubMed. The Molecular Logic of Immunoglobulin Heavy Chain Class Switch Recombination Signals from nearby T cells steer which class a cell switches to.22PubMed Central. Immunoglobulin class‐switch recombination: Mechanism, regulation, and related diseases You may see these names on lab reports:
- IgM: the first antibody made in a new infection.
- IgG: the main long-lasting antibody in blood.
- IgA: guards mucous surfaces like the gut and airways.
- IgE: involved in allergies.
Antibody Factories and Memory Cells
Some trained B cells become plasma cells, factories that release large amounts of antibody. The longest-lived ones move to the bone marrow, where they can survive for decades.23PubMed. Long-lived plasma cells accumulate in the bone marrow at a constant rate from early in an immune response Special support cells in the marrow keep them alive.24PubMed. Stromal niches, plasma cell differentiation and survival To fuel antibody production, these cells switch to burning lots of sugar.25PubMed. Fuelling B cells: dynamic regulation of B cell metabolism
Antibody levels drop after the first weeks, but long-lived factories keep a low, steady supply going, so a falling antibody test doesn’t mean protection is gone. Some germs also change shape so old antibodies fit poorly, which is one reason some vaccines need updates.
Other trained cells become memory B cells that respond faster and stronger on re-exposure.26PubMed. Molecular and tissue regulation of memory B cells A trained cell doesn’t become both at once. It commits to one path, and the strength of its grip influences which. Cells that bind very tightly tend to be steered toward becoming factories, while others are more likely to enter the memory pool. Some cells cycle back through the training zone for more rounds before choosing a fate.27PubMed Central. B cell memory: from generation to reactivation: a multipronged defense wall against pathogens
Memory cells circulate quietly, releasing little antibody until the germ returns. Then they recognize it quickly and multiply, and many turn into factories within days, so antibody levels rise faster and higher than the first time. That can stop an infection before symptoms appear or make it milder.
B Cells Do More Than Make Antibodies
B cells can activate helper and killer T cells.28PubMed Central. Role of B cells as antigen presenting cells A B cell can pick up a germ using its specific receptor and show fragments to T cells, which is efficient when the germ is scarce because the receptor concentrates it. For some virus-like particles, B cells are the main cells that start helper T cell responses.29PubMed. B Cells Are the Dominant Antigen-Presenting Cells that Activate Naive CD4(+) T Cells upon Immunization with a Virus-Derived Nanoparticle Antigen Some of the T cells they activate later give help back in training zones.
B cells also release chemical messengers that help build and maintain lymph nodes.30PubMed. Antibody-independent functions of B cells: a focus on cytokines Nodes have separate zones for B cells and T cells, and without that layout the meetings that start antibody responses would be less efficient.
Not all B cells are alike. Most are standard cells that form training zones, while others sit at blood filters in the spleen and react fast, tending to respond without T-cell help.31PubMed. Enhanced IgA class switching in marginal zone and B1 B cells relative to follicular/B2 B cells
A group called regulatory B cells restrains excess inflammation.32PubMed. Immune regulatory function of B cells They release a messenger that dampens inflammatory signals.33PubMed. Immune regulatory function of B cells Other B cells release messengers that boost inflammation, depending on what stimulates them.34PubMed Central. B cells responses and cytokine production are regulated by their immune microenvironment Problems in these roles appear in many inflammatory diseases.35PubMed Central. Cytokine-producing B lymphocytes – key regulators of immunity
When B Cells Turn Against the Body
In lupus, self-reactive B cells that should be removed after leaving the marrow survive instead.36PubMed Central. Defective B cell tolerance checkpoints in systemic lupus erythematosus In some people with lupus, roughly 4 to 5 in 10 mature B cells made antibodies reacting to cell contents, versus 2 in 10 in healthy people.37PubMed Central. Defective B cell tolerance checkpoints in systemic lupus erythematosus The figures describe some patients, not everyone with the disease. A sensor inside B cells that detects genetic material can also push them to make antibodies outside normal training zones in lupus.38PubMed Central. Toll-like receptor signalling in B cells during systemic lupus erythematosus
An ANA test looks for antibodies against the body’s own cell contents. These come from B cells that escaped the safety check. A positive ANA alone doesn’t diagnose lupus, and doctors combine it with symptoms, partly because some healthy people test positive.
Autoantibodies can bind the body’s own molecules and form clumps that lodge in tissues such as the kidneys and skin. These clumps attract other immune cells and trigger inflammation, which is how a misdirected antibody turns into symptoms. Because targets differ, different autoimmune diseases affect different organs even though the underlying B-cell problem is similar.
Treatments That Target B Cells
Rituximab is an antibody drug that tags B cells for removal and is used in rheumatoid arthritis and some lupus cases.39PubMed Central. Internalization of Rituximab and the Efficiency of B Cell Depletion in Rheumatoid Arthritis and Systemic Lupus Erythematosus It recognizes a marker called CD20 on many B cells, so it clears those carrying it from the blood. Young cells still in the marrow and long-lived antibody factories lack that marker, so they aren’t removed. That’s why the drug can reduce disease activity without leaving a person completely without antibodies.
How well it clears B cells varies between patients, partly because some B cells pull the drug inside and escape.40PubMed Central. Internalization of Rituximab and the Efficiency of B Cell Depletion in Rheumatoid Arthritis and Systemic Lupus Erythematosus Newer antibodies designed to avoid this cleared B cells at least twice as well in lab tests on patient blood.41PubMed Central. Internalization of Rituximab and the Efficiency of B Cell Depletion in Rheumatoid Arthritis and Systemic Lupus Erythematosus
Because the factories survive, old antibodies often persist during treatment. Responses to new vaccines may be weaker, so ask your doctor about timing vaccines around doses. B cells regrow over months after stopping.
How Aging Changes B Cells
Antibody responses to flu vaccines are lower in people over 65.42PubMed Central. Age effects on B cells and humoral immunity in humans Responses to tetanus, pneumococcus, and other vaccines also decline with age.43PubMed Central. Age effects on B cells and humoral immunity in humans Older B cells make less AID and switch classes less well,44PubMed Central. Aging Affects Human B Cell Responses and fewer switched memory cells and long-lived factories form.45PubMed Central. AGE-RELATED FACTORS THAT AFFECT B CELL RESPONSES TO VACCINATION IN MICE AND HUMANS
A lower antibody response doesn’t mean a vaccine does nothing, since vaccination can still reduce the chance of severe illness. This is a pattern across groups, and individual older people differ widely.
High-dose or boosted flu vaccines exist for older people, and staying current on boosters helps compensate. A pharmacist can tell you which version suits your age.